Candriam SCA’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $151M | Buy |
328,149
+37,107
| +13% | +$18.8M | 0.79% | 23 |
|
|
2025
Q4 | $165M | Buy |
291,042
+20,962
| +8% | +$11.2M | 0.82% | 20 |
|
|
2025
Q3 | $121M | Sell |
270,080
-63,466
| -19% | -$30.5M | 0.63% | 29 |
|
|
2025
Q2 | $181M | Sell |
333,546
-16,385
| -5% | -$8.57M | 1.05% | 13 |
|
|
2025
Q1 | $173M | Buy |
349,931
+102,304
| +41% | +$56.6M | 1.09% | 18 |
|
|
2024
Q4 | $129M | Buy |
247,627
+17,401
| +8% | +$9.06M | 0.74% | 27 |
|
|
2024
Q3 | $113M | Sell |
230,226
-16,641
| -7% | -$7.75M | 0.65% | 28 |
|
|
2024
Q2 | $110M | Sell |
246,867
-10,200
| -4% | -$4.06M | 0.67% | 29 |
|
|
2024
Q1 | $103M | Sell |
257,067
-51,337
| -17% | -$19.4M | 0.66% | 32 |
|
|
2023
Q4 | $104M | Sell |
308,404
-26,922
| -8% | -$8.03M | 0.72% | 26 |
|
|
2023
Q3 | $98M | Buy |
335,326
+108,332
| +48% | +$33.8M | 0.69% | 25 |
|
|
2023
Q2 | $77.6M | Sell |
226,994
-23,950
| -10% | -$7.25M | 0.56% | 35 |
|
|
2023
Q1 | $59M | Buy |
250,944
+80,774
| +47% | +$19.9M | 0.41% | 56 |
|
|
2022
Q4 | $45.2M | Sell |
170,170
-21,012
| -11% | -$5.12M | 0.3% | 80 |
|
|
2022
Q3 | $35.8M | Buy |
191,182
+31,745
| +20% | +$6.82M | 0.25% | 91 |
|
|
2022
Q2 | $32M | Buy |
159,437
+4,019
| +3% | +$943K | 0.26% | 94 |
|
|
2022
Q1 | $46.9M | Buy |
155,418
+14,113
| +10% | +$4.12M | 0.32% | 75 |
|
|
2021
Q4 | $50.8M | Buy |
141,305
+4,151
| +3% | +$1.43M | 0.32% | 75 |
|
|
2021
Q3 | $45.4M | Sell |
137,154
-564
| -0.4% | -$189K | 0.31% | 80 |
|
|
2021
Q2 | $42.2M | Buy |
137,718
+10,536
| +8% | +$2.96M | 0.29% | 80 |
|
|
2021
Q1 | $33.3M | Hold |
127,182
| – | – | 0.28% | 89 |
|
|
2020
Q4 | $34.7M | Buy |
127,182
+3,936
| +3% | +$977K | 0.27% | 89 |
|
|
2020
Q3 | $29.1M | Buy |
123,246
+9,084
| +8% | +$2.04M | 0.27% | 84 |
|
|
2020
Q2 | $21.7M | Sell |
114,162
-1,236
| -1% | -$222K | 0.23% | 111 |
|
|
2020
Q1 | $22.2M | Hold |
115,398
| – | – | 0.25% | 84 |
|
|
2019
Q4 | $22.7M | Sell |
115,398
-20,307
| -15% | -$3.8M | 0.24% | 84 |
|
|
2019
Q3 | $24.4M | Buy |
135,705
+70,497
| +108% | +$12.2M | 0.32% | 58 |
|
|
2019
Q2 | $11.4M | Sell |
65,208
-51,714
| -44% | -$8.86M | 0.14% | 167 |
|
|
2019
Q1 | $22.2M | Sell |
116,922
-20,916
| -15% | -$3.72M | 0.28% | 79 |
|
|
2018
Q4 | $22M | Sell |
137,838
-34,563
| -20% | -$5.86M | 0.34% | 56 |
|
|
2018
Q3 | $33M | Buy |
172,401
+9,522
| +6% | +$1.69M | 0.44% | 45 |
|
|
2018
Q2 | $26M | Sell |
162,879
-41,595
| -20% | -$6.34M | 0.41% | 49 |
|
|
2018
Q1 | $28.1M | Buy |
204,474
+17,907
| +10% | +$2.5M | 0.48% | 40 |
|
|
2017
Q4 | $22.7M | Sell |
186,567
-17,850
| -9% | -$2.23M | 0.39% | 64 |
|
|
2017
Q3 | $23.8M | Buy |
204,417
+19,872
| +11% | +$2.17M | 0.42% | 57 |
|
|
2017
Q2 | $19.2M | Buy |
184,545
+25,020
| +16% | +$2.4M | 0.36% | 61 |
|
|
2017
Q1 | $13.6M | Buy |
159,525
+4,833
| +3% | +$382K | 0.26% | 100 |
|
|
2016
Q4 | $10.9M | Buy |
154,692
+139,932
| +948% | +$10.3M | 0.25% | 106 |
|
|
2016
Q3 | $1.19M | Buy |
14,760
+3,933
| +36% | +$301K | 0.03% | 463 |
|
|
2016
Q2 | $796K | Buy |
10,827
+2,799
| +35% | +$197K | 0.02% | 480 |
|
|
2016
Q1 | $533K | Sell |
8,028
-21,663
| -73% | -$1.34M | 0.01% | 541 |
|
|
2015
Q4 | $1.8M | Sell |
29,691
-7,920
| -21% | -$445K | 0.05% | 314 |
|
|
2015
Q3 | $1.92M | Buy |
37,611
+2,043
| +6% | +$116K | 0.05% | 349 |
|
|
2015
Q2 | $1.92M | Hold |
35,568
| – | – | 0.04% | 371 |
|
|
2015
Q1 | $2M | Buy |
35,568
+7,200
| +25% | +$408K | 0.04% | 386 |
|
|
2014
Q4 | $1.67M | Buy |
+28,368
| New | +$1.58M | 0.03% | 381 |
|
Other funds holding ISRG
VCM
VPM
Candriam SCA's ISRG Position: Q1 2026 in Review
Candriam SCA increased its Intuitive Surgical (ISRG) stake by 13% in Q1 2026, buying an estimated $18.8M and bringing the position to 328,149 shares worth $151M. The position accounts for 0.79% of the portfolio, ranked #23.
Candriam SCA first reported a position in ISRG in Q4 2014 and has held it in 46 quarters since. The position peaked at $181M in Q2 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Candriam SCA held 328,149 shares of Intuitive Surgical worth $151M as of Q1 2026.
- Candriam SCA bought 37,107 Intuitive Surgical shares in Q1 2026, an estimated $18.8M.
- Intuitive Surgical made up 0.79% of Candriam SCA's portfolio in Q1 2026, its #23 holding.
- Candriam SCA first reported a position in Intuitive Surgical in Q4 2014 and has held it in 46 quarters since.
- Candriam SCA's Intuitive Surgical position peaked at $181M in Q2 2025.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.